Hiromichi Ishiyama

Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for Stage II-III Esophageal Carcinoma

K. Kato, Takako Eguchi Nakajima, Y. Ito et al. · Japanese Journal of Clinical Oncology · 2013 · 92 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2)

Katsuhiko Higuchi, Shouko Komori, Satoshi Tanabe et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 84 citations

Medicine, Oncology, Radiation Oncology +16

Spontaneous Regression of Thoracic Metastases While Progression of Brain Metastases After Stereotactic Radiosurgery and Stereotactic Body Radiotherapy for Metastatic Renal Cell Carcinoma: Abscopal Effect Prevented by the Blood-Brain Barrier?

Hiromichi Ishiyama, Bin S. Teh, Hua Ren et al. · Clinical Genitourinary Cancer · 2012 · 76 citations

Medicine, Oncology, Radiation Oncology +17

MicroRNA-221 and -222 Regulate Radiation Sensitivity by Targeting the PTEN Pathway

Chunzhi Zhang, Chunsheng Kang, Ping Wang et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 64 citations

Medicine, Molecular Biology, Oncology +14

The kinetochore protein Bub1 participates in the DNA damage response

Chunying Yang, Haibo Wang, Yiran Xu et al. · DNA repair · 2011 · 56 citations

Life Sciences, Genetics, Molecular Biology +14